NICARDIPINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nicardipine Hydrochloride, and when can generic versions of Nicardipine Hydrochloride launch?
Nicardipine Hydrochloride is a drug marketed by Amneal, Ani Pharms, Bionpharma, Epic Pharma Llc, Glenmark Pharms Ltd, Navinta Llc, Pharmobedient, Senores Pharms, Am Regent, Chengdu Shuode, Eugia Pharma, Hikma, Hikma Intl Pharms, Mankind Pharma, Micro Labs, Nanjing King Friend, Qilu Pharm Hainan, Somerset Theraps Llc, Sun Pharm, Inforlife, Caplin, and Cipla. and is included in twenty-six NDAs.
The generic ingredient in NICARDIPINE HYDROCHLORIDE is nicardipine hydrochloride. There are eleven drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the nicardipine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nicardipine Hydrochloride
A generic version of NICARDIPINE HYDROCHLORIDE was approved as nicardipine hydrochloride by ANI PHARMS on October 28th, 1996.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for NICARDIPINE HYDROCHLORIDE?
- What are the global sales for NICARDIPINE HYDROCHLORIDE?
- What is Average Wholesale Price for NICARDIPINE HYDROCHLORIDE?
Summary for NICARDIPINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 22 |
| NDAs: | 26 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for NICARDIPINE HYDROCHLORIDE |
Paragraph IV (Patent) Challenges for NICARDIPINE HYDROCHLORIDE
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER | Injection | nicardipine hydrochloride | 2.5 mg/mL, 10 mL Ampoules | 019734 | 1 | 2006-12-27 |
